DK0781341T3 - Fremgangsmåde til fremstilling af rekombinante proteiner, plasmider og modificerede celler - Google Patents

Fremgangsmåde til fremstilling af rekombinante proteiner, plasmider og modificerede celler

Info

Publication number: DK0781341T3
Authority: DK; Denmark
Prior art keywords: plasmids; pct; preparation; recombinant proteins; modified cells
Prior art date: 1994-09-16

Application number

DK95931242T

Other languages

Danish (da)

English (en)

Inventor

Beatrice Cameron

Joeel Crouzet

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-16

Filing date

1995-09-14

Publication date

2009-01-05

1995-09-14 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2009-01-05 Application granted granted Critical

2009-01-05 Publication of DK0781341T3 publication Critical patent/DK0781341T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
- C12N15/68—Stabilisation of the vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

DK95931242T 1994-09-16 1995-09-14 Fremgangsmåde til fremstilling af rekombinante proteiner, plasmider og modificerede celler DK0781341T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9411049A FR2724665B1 (fr)	1994-09-16	1994-09-16	Procede de production de proteines recombinantes, plasmides et cellules modifiees
PCT/FR1995/001178 WO1996008572A1 (fr)	1994-09-16	1995-09-14	Procede de production de proteines recombinantes, plasmides et cellules modifiees

Publications (1)

Publication Number	Publication Date
DK0781341T3 true DK0781341T3 (da)	2009-01-05

Family

ID=9466987

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95931242T DK0781341T3 (da)	1994-09-16	1995-09-14	Fremgangsmåde til fremstilling af rekombinante proteiner, plasmider og modificerede celler

Country Status (19)

Country	Link
US (1)	US6143518A (fi)
EP (1)	EP0781341B1 (fi)
JP (1)	JP3696247B2 (fi)
KR (1)	KR100391752B1 (fi)
AT (1)	ATE405656T1 (fi)
AU (1)	AU708080B2 (fi)
CA (1)	CA2197804C (fi)
DE (1)	DE69535815D1 (fi)
DK (1)	DK0781341T3 (fi)
ES (1)	ES2313721T3 (fi)
FI (1)	FI120238B (fi)
FR (1)	FR2724665B1 (fi)
IL (1)	IL115308A (fi)
MX (1)	MX9701614A (fi)
NO (1)	NO320374B1 (fi)
PT (1)	PT781341E (fi)
TW (1)	TW517086B (fi)
WO (1)	WO1996008572A1 (fi)
ZA (1)	ZA957750B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9618001D0 (en) *	1996-08-29	1996-10-09	Nyfotek As	Novel expression vectors
US20060281681A1 (en)	1997-05-28	2006-12-14	Pilon Aprile L	Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
EP0998945A1 (en) *	1998-09-30	2000-05-10	Transgene S.A.	Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
EP1022337B1 (en) *	1999-01-20	2006-07-26	Bayer HealthCare AG	Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins
DE69929638T2 (de)	1999-01-20	2006-09-21	Bayer Healthcare Ag	Plasmide, deren Konstruktion und Anwendung zur Herstellung von Interleukin-4 und dessen Muteine
NZ518963A (en) *	1999-10-19	2002-11-26	Bharat Biotech International L	Expression of recombinant mature lysostaphin
US9051589B2 (en) *	2005-10-27	2015-06-09	Kaneka Corporation	Plasmid vector and transformant stably retaining plasmid
JP5650368B2 (ja) *	2005-10-27	2015-01-07	株式会社カネカ	新規プラスミドベクター及びプラスミドを安定に保持する形質転換体
MX2010012234A (es)	2008-05-13	2011-03-03	Clarassance Inc	Cc10 humana recombinante y composiciones del mismo para uso en el tratamiento de rinitis nasal.
US9168285B2 (en)	2009-10-15	2015-10-27	Therabron Therapeutics, Inc.	Recombinant human CC10 protein for treatment of influenza and ebola
MX2012004409A (es)	2009-10-15	2012-08-23	Clarassance Inc	Proteina recombinante de humano cc10 para el tratamiento de la influenza.
BR102014014502B1 (pt) *	2014-06-13	2020-09-15	Ouro Fino Saúde Animal Ltda	Vetor de expressão

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK410783D0 (da) *	1982-09-16	1983-09-09	Benzon A Salfred	Fremgangsmade til stabilisering af plasmider
DE3247922A1 (de) *	1982-12-24	1984-06-28	Boehringer Ingelheim International GmbH, 6507 Ingelheim	Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
NZ220917A (en) *	1986-07-11	1991-05-28	Merck & Co Inc	Human and bovine acidic fibroblast growth factor vectors, hosts and compositions
US5175147A (en) *	1988-08-19	1992-12-29	Takeda Chemical Industries, Ltd	Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
FR2642086B1 (fr) *	1989-01-26	1992-09-04	Sanofi Sa	Gene recombinant codant pour un facteur basique de croissance des fibroblastes et ledit facteur
EP0406738A3 (en) *	1989-07-03	1991-08-14	Takeda Chemical Industries, Ltd.	Production of acidic fgf protein
FR2661188B1 (fr) *	1990-04-24	1994-07-22	Rhone Poulenc Sante	Nouveaux vecteurs de clonage et/ou d'expression, procede de preparation et leur utilisation.

1994
- 1994-09-16 FR FR9411049A patent/FR2724665B1/fr not_active Expired - Lifetime
1995
- 1995-09-14 ES ES95931242T patent/ES2313721T3/es not_active Expired - Lifetime
- 1995-09-14 WO PCT/FR1995/001178 patent/WO1996008572A1/fr active IP Right Grant
- 1995-09-14 US US08/793,900 patent/US6143518A/en not_active Expired - Lifetime
- 1995-09-14 DE DE69535815T patent/DE69535815D1/de not_active Expired - Lifetime
- 1995-09-14 JP JP50995996A patent/JP3696247B2/ja not_active Expired - Fee Related
- 1995-09-14 AT AT95931242T patent/ATE405656T1/de active
- 1995-09-14 EP EP95931242A patent/EP0781341B1/fr not_active Expired - Lifetime
- 1995-09-14 KR KR1019970701694A patent/KR100391752B1/ko not_active Expired - Lifetime
- 1995-09-14 PT PT95931242T patent/PT781341E/pt unknown
- 1995-09-14 AU AU34754/95A patent/AU708080B2/en not_active Expired
- 1995-09-14 IL IL115308A patent/IL115308A/en not_active IP Right Cessation
- 1995-09-14 DK DK95931242T patent/DK0781341T3/da active
- 1995-09-14 ZA ZA957750A patent/ZA957750B/xx unknown
- 1995-09-14 MX MX9701614A patent/MX9701614A/es unknown
- 1995-09-14 CA CA2197804A patent/CA2197804C/fr not_active Expired - Fee Related
- 1995-09-16 TW TW084109710A patent/TW517086B/zh not_active IP Right Cessation
1997
- 1997-03-12 NO NO19971139A patent/NO320374B1/no not_active IP Right Cessation
- 1997-03-14 FI FI971100A patent/FI120238B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI971100L (fi)	1997-03-14
FI971100A0 (fi)	1997-03-14
FR2724665B1 (fr)	1996-12-20
TW517086B (en)	2003-01-11
NO971139L (no)	1997-03-12
CA2197804A1 (fr)	1996-03-21
AU3475495A (en)	1996-03-29
JPH10505746A (ja)	1998-06-09
PT781341E (pt)	2008-11-20
US6143518A (en)	2000-11-07
FI120238B (fi)	2009-08-14
EP0781341B1 (fr)	2008-08-20
CA2197804C (fr)	2010-11-16
MX9701614A (es)	1997-06-28
JP3696247B2 (ja)	2005-09-14
ZA957750B (en)	1996-04-24
FR2724665A1 (fr)	1996-03-22
EP0781341A1 (fr)	1997-07-02
KR100391752B1 (ko)	2003-10-22
ATE405656T1 (de)	2008-09-15
DE69535815D1 (de)	2008-10-02
IL115308A (en)	2009-07-20
NO320374B1 (no)	2005-11-28
AU708080B2 (en)	1999-07-29
ES2313721T3 (es)	2009-03-01
WO1996008572A1 (fr)	1996-03-21
IL115308A0 (en)	1995-12-31
NO971139D0 (no)	1997-03-12

Publication	Publication Date	Title
DK0575443T3 (da)	1997-12-29	Ærteproteinhydrolysat, fremgangsmåde til dets fremstilling og anvendelse deraf
DE50013610D1 (de)	2006-11-23	Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
ATE177473T1 (de)	1999-03-15	Herstellung von rekombinanten, menschlichem lactoferrin
NO950534L (no)	1995-04-05	Modufiserte soppceller og fremgangsmåter for fremstilling av rekombinante produkter
DK1093517T3 (da)	2008-06-23	Neisseria-meningitidis-antigener og præparater
DK0781341T3 (da)	2009-01-05	Fremgangsmåde til fremstilling af rekombinante proteiner, plasmider og modificerede celler
ATE449850T1 (de)	2009-12-15	Mutanten von flt3-l und ihre verwendungen
HUT68021A (en)	1995-04-04	Improved activating process of recombinant proteins
DK0851926T3 (da)	2003-08-18	Varianter af humant rekombinant gamminterferon (rhu-IFN-gamma) med forøget termisk stabilitet
DK1025236T3 (da)	2005-10-24	Human checkpoint kinase, HCDS1, præparater og fremgangsmåde
DK0562508T3 (da)	1999-03-29	Nyt knogle-relateret protein OSF-2, fremgangsmåde til dets fremstilling samt farmaceutisk præparat med indhold deraf
NO971621L (no)	1997-06-12	Keratinocyttvekstfaktoranaloger
AUPN154295A0 (en)	1995-03-30	Nucleic acid molecule encoding a protein with avian gamma-interferon activity
FI940036A0 (fi)	1994-01-04	Nukleotidisekvenssejä ja sykloheksimidiresistenssejä proteiineja
FI930626A0 (fi)	1993-02-12	Proteinstruktur hos vaexttoxingelonin
ES2114555T3 (es)	1998-06-01	Nuevo interferon gamma humano recombinado.
ATE233321T1 (de)	2003-03-15	Verbesserungen in der herstellung von proteinen in wirtszellen
AU637589B2 (en)	1993-06-03	Ancrod proteins, their production and use